mercredi 23 novembre 2016
Eli Lilly Alzheimer's treatment drug fails in study, company says
An experimental treatment for Alzheimer's failed again in a widely anticipated study, disappointing many who had hoped drugmaker Eli Lilly had finally found a way to slow the progression of the mind-robbing disease.
Related Posts:
Being addicted to technology is not the same as being literate in it- Ontario coroner to implement new death investigations for quicker opioid death data
- Class-action suit filed over E. coli contaminated Robin Hood flour
- Class-action suit filed over E. coli contaminated Robin Hood flour
- Ontario coroner to implement new death investigations for quicker opioid death data
Articles
0 comments:
Enregistrer un commentaire